2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Melanoma
Lisa Kottschade, APRN, MSN, CNP
J Adv Pract Oncol 2019;10(6):585-589 |
© 2019 Harborside™
In recent years, there has been an explosion of therapies for the treatment of melanoma, including BRAF mutation–guided therapy. With coverage by The ASCO Post, Lisa Kottschade, APRN, MSN, CNP, of the Mayo Clinic reviews clinical data supporting emerging targeted therapies and immunotherapies, and shares considerations on patient selection, education, and adverse event management.
For access to the full length article, please sign in